{{Rsnum
|rsid=3923086
|Gene=AXIN2
|Chromosome=17
|position=65553370
|Orientation=minus
|GMAF=0.3177
|Gene_s=AXIN2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 29.5 | 45.5 | 25.0
| HCB | 2.9 | 27.7 | 69.3
| JPT | 2.7 | 26.5 | 70.8
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 21.1 | 78.9
| CHB | 2.9 | 27.7 | 69.3
| CHD | 4.6 | 26.9 | 68.5
| GIH | 12.9 | 51.5 | 35.6
| LWK | 0.0 | 2.7 | 97.3
| MEX | 19.3 | 61.4 | 19.3
| MKK | 0.0 | 14.7 | 85.3
| TSI | 21.6 | 45.1 | 33.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=22370446
|Title=Association of AXIN2 with non-syndromic oral clefts in multiple populations
|OA=1
}}

{{PMID Auto
|PMID=18708403
|Title=Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer.
|OA=1
}}

{{PMID Auto
|PMID=23516639
|Title=Association of single nucleotide polymorphisms in wnt signaling pathway genes with breast cancer in saudi patients
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}